FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1845769873> ?p ?o ?g. }

• W1845769873 endingPage "1510" @default.
• W1845769873 startingPage "1500" @default.
• W1845769873 abstract "Idiopathic pulmonary fibrosis is an inexorably progressive lung disease with few available treatments. New therapeutic options are needed. Stem cells have generated much enthusiasm for the treatment of several conditions, including lung diseases. Human trials of mesenchymal stromal cell (MSC) therapy for pulmonary fibrosis are under way. To shed light on the potential usefulness of MSCs for human disease, we aimed to systematically review the preclinical literature to determine if MSCs are beneficial in animal bleomycin pulmonary fibrosis models. The MEDLINE and Embase databases were searched for original studies of stem cell therapy in animal bleomycin models of pulmonary fibrosis. Studies using embryonic stem cells or induced pluripotent stem cells were excluded. Seventeen studies were selected, all of which used MSCs in rodents. MSC therapy led to an improvement in bleomycin-induced lung collagen deposition in animal lungs and in the pulmonary fibrosis Ashcroft score in most studies. MSC therapy improved histopathology in almost all studies in which it was evaluated qualitatively. Furthermore, MSC therapy was found to improve 14-day survival in animals with bleomycin-induced pulmonary fibrosis. Bronchoalveolar lavage total and neutrophil counts, as well as transforming growth factor-β levels, were also reduced by MSCs. MSCs are beneficial in rodent bleomycin pulmonary fibrosis models. Since most studies examined the initial inflammatory phase rather than the chronic fibrotic phase, preclinical data offer better support for human trials of MSCs in acute exacerbations of pulmonary fibrosis rather than the chronic phase of the disease.There has been increased interest in mesenchymal stromal cell therapy for lung diseases. A few small clinical trials are under way in idiopathic pulmonary fibrosis. Preclinical evidence was assessed in a systematic review, as is often done for clinical studies. The existing studies offer better support for efficacy in the initial inflammatory phase rather than the fibrotic phase that human trials are targeting." @default.
• W1845769873 created "2016-06-24" @default.
• W1845769873 creator A5051658775 @default.
• W1845769873 creator A5065342095 @default.
• W1845769873 date "2015-10-22" @default.
• W1845769873 modified "2023-10-01" @default.
• W1845769873 title "Mesenchymal Stromal Cells in Animal Bleomycin Pulmonary Fibrosis Models: A Systematic Review" @default.
• W1845769873 cites W1493760002 @default.
• W1845769873 cites W1966267138 @default.
• W1845769873 cites W1966683354 @default.
• W1845769873 cites W1971022336 @default.
• W1845769873 cites W1971792838 @default.
• W1845769873 cites W1972196663 @default.
• W1845769873 cites W1972243974 @default.
• W1845769873 cites W1972319394 @default.
• W1845769873 cites W1978825438 @default.
• W1845769873 cites W1980246060 @default.
• W1845769873 cites W1984560751 @default.
• W1845769873 cites W1988009177 @default.
• W1845769873 cites W1999705683 @default.
• W1845769873 cites W1999713206 @default.
• W1845769873 cites W2002463857 @default.
• W1845769873 cites W2019521786 @default.
• W1845769873 cites W2022915249 @default.
• W1845769873 cites W2024722141 @default.
• W1845769873 cites W2024781408 @default.
• W1845769873 cites W2029532220 @default.
• W1845769873 cites W2029584195 @default.
• W1845769873 cites W2031790029 @default.
• W1845769873 cites W2032607262 @default.
• W1845769873 cites W2038726367 @default.
• W1845769873 cites W2040916070 @default.
• W1845769873 cites W2046474617 @default.
• W1845769873 cites W2047003893 @default.
• W1845769873 cites W2049069390 @default.
• W1845769873 cites W2051162734 @default.
• W1845769873 cites W2055289656 @default.
• W1845769873 cites W2056158473 @default.
• W1845769873 cites W2057292199 @default.
• W1845769873 cites W2061264372 @default.
• W1845769873 cites W2065972887 @default.
• W1845769873 cites W2079335753 @default.
• W1845769873 cites W2085163273 @default.
• W1845769873 cites W2085604666 @default.
• W1845769873 cites W2085887779 @default.
• W1845769873 cites W2090625436 @default.
• W1845769873 cites W2095443864 @default.
• W1845769873 cites W2098530232 @default.
• W1845769873 cites W2107395201 @default.
• W1845769873 cites W2111985460 @default.
• W1845769873 cites W2122083530 @default.
• W1845769873 cites W2125639937 @default.
• W1845769873 cites W2133375451 @default.
• W1845769873 cites W2138871107 @default.
• W1845769873 cites W2148231557 @default.
• W1845769873 cites W2150103989 @default.
• W1845769873 cites W2152999504 @default.
• W1845769873 cites W2161006376 @default.
• W1845769873 cites W2161164938 @default.
• W1845769873 cites W2165440991 @default.
• W1845769873 cites W2167189518 @default.
• W1845769873 cites W2168666423 @default.
• W1845769873 cites W2168750058 @default.
• W1845769873 cites W2172038685 @default.
• W1845769873 cites W4296816736 @default.
• W1845769873 doi "https://doi.org/10.5966/sctm.2015-0121" @default.
• W1845769873 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4675510" @default.
• W1845769873 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26494779" @default.
• W1845769873 hasPublicationYear "2015" @default.
• W1845769873 type Work @default.
• W1845769873 sameAs 1845769873 @default.
• W1845769873 citedByCount "89" @default.
• W1845769873 countsByYear W18457698732016 @default.
• W1845769873 countsByYear W18457698732017 @default.
• W1845769873 countsByYear W18457698732018 @default.
• W1845769873 countsByYear W18457698732019 @default.
• W1845769873 countsByYear W18457698732020 @default.
• W1845769873 countsByYear W18457698732021 @default.
• W1845769873 countsByYear W18457698732022 @default.
• W1845769873 countsByYear W18457698732023 @default.
• W1845769873 crossrefType "journal-article" @default.
• W1845769873 hasAuthorship W1845769873A5051658775 @default.
• W1845769873 hasAuthorship W1845769873A5065342095 @default.
• W1845769873 hasBestOaLocation W18457698731 @default.
• W1845769873 hasConcept C10882517 @default.
• W1845769873 hasConcept C126322002 @default.
• W1845769873 hasConcept C142724271 @default.
• W1845769873 hasConcept C16930146 @default.
• W1845769873 hasConcept C198826908 @default.
• W1845769873 hasConcept C203014093 @default.
• W1845769873 hasConcept C2776232574 @default.
• W1845769873 hasConcept C2776694085 @default.
• W1845769873 hasConcept C2777714996 @default.
• W1845769873 hasConcept C2778341716 @default.
• W1845769873 hasConcept C2780559512 @default.
• W1845769873 hasConcept C2781244666 @default.
• W1845769873 hasConcept C28328180 @default.
• W1845769873 hasConcept C502942594 @default.

• next